Real-World Effectiveness and Safety of Tucatinib, Trastuzumab, and Capecitabine in HER2-Positive Advanced Breast Cancer: A Multicenter Portuguese Study.

Saved in:
Bibliographic Details
Title: Real-World Effectiveness and Safety of Tucatinib, Trastuzumab, and Capecitabine in HER2-Positive Advanced Breast Cancer: A Multicenter Portuguese Study.
Authors: Ferreira, Rita Quaresma1 (AUTHOR) ritaquaferreira@hotmail.com, Monteiro, Carolina Brandão2 (AUTHOR), Dias, Ana Catarina3 (AUTHOR), Abreu, Francisca3 (AUTHOR), Darmits, Bogdana4 (AUTHOR), Oura, Maria João5 (AUTHOR), Ângelo, Inês6 (AUTHOR), Cabral, Joana7 (AUTHOR), Figueiredo, Alice8 (AUTHOR), Ferreira, Ricardo9 (AUTHOR), Costa, Diogo Alpuim10 (AUTHOR), Marques, Maria Teresa11 (AUTHOR), Pina-Cabral, Tiago12 (AUTHOR), Araújo, Filipe13 (AUTHOR), Bento, Sandra14 (AUTHOR), Fernandes, Catarina Lopes15 (AUTHOR), Santiago, Mariana16 (AUTHOR), Silva, Bruno17 (AUTHOR), Montenegro, Maria Alexandra1 (AUTHOR), Simão, Diana Cardoso1 (AUTHOR)
Source: European Journal of Breast Health. 2026, Vol. 22 Issue 3, p318-327. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:25870831
DOI:10.4274/ejbh.galenos.2026.2026-2-3